Publications of A Henning

Henning, A.: High Field Metabolic Imaging: from system architecture to application. Medical Physics Seminary: Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany (2013)

Henning, A.: MR Spectroscopic Imaging in Oncology. Biomedica 2013: The 7th European Life Sciences Summit, Aachen, Germany (2013)

Scheidegger, M.; Fuchs A, Lehmann M, Grimm S, Boeker H, Seifritz, E.; Henning, A.: Effect of an antidepressant dose of Ketamine on prefrontal aspartate, glutamine and GABA levels in healthy subjects: assessing the post-infusion interval with 1H MRS. 21st Annual Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine (ISMRM 2013), Salt Lake City, UT, USA (2013)

Henning, A.: Ultra-high field human MRI and MRS. Danish Research Centre for Magnetic Resonance (DRCMR), Copenhagen, Denmark (2013)

Henning, A.: High Resolution 1H MRS Imaging. ISMRM Scientific Workshop on Ultra High Field MRI: What is in Full Bloom & What is Sprouting?, Noordwijk aan Zee, The Netherlands (2013)

Henning, A.: In vivo MR spectroscopy at high and ultra-high field strength. MRI Seminar: University of Texas South West, Dallas, TX, USA (2012)

Henning, A.: MultiTX and Dynamic B0 Shim Updating. Philips Medical Systems: 7T User Meeting, Columbus, OH, USA (2012)

Scheidegger, M.; Walter, M.; Lehmann, M.; Metzger, C.; Grimm, S.; Boeker, H.; Boesiger, P.; Henning, A.; Seifritz, E.: Ketamine decreases resting state functional connectivity between networks via the dorsal nexus: implications for major depression. Third Biennial Conference on Resting State Brain Connectivity, Magdeburg, Germany (2012)

Henning, A.: In vivo MR spectroscopy at high and ultra-high field strength. Research Seminar GE Global Research, München, Germany (2012)

Henning, A.: In vivo MR spectroscopy at high and ultra-high field strength. Maastricht University, Maastricht, The Netherlands (2012)

Henning, A.: In vivo MR spectroscopy at high and ultra-high field strength. Cardiology Seminar: University of Aberdeen, Aberdeen, UK (2012)

Henning, A.: In vivo NMR spectroscopy at ultra-high field: chances and challenges. XIXth Swiss NMR Symposium 2012 , Bern, Switzerland (2012)

Henning, A.: In vivo MR spectroscopy at high and ultra-high field strength. Research Seminar: Max-Planck-Institut für Biologische Kybernetik, Tübingen, Germany (2011)

Henning, A.: In vivo MRS at high and ultra-high fields. CIBM HUG Seminar: University of Geneva, Geneva, Switzerland (2010)

Henning, A.: Ongoing spectroscopy projects, Philips Medical Systems. Philips Medical Systems: 7T User Meeting, Noordwijk, The Netherlands (2010)

Henning, A.: Advances in MR spectroscopy at higher fields and applications of glutamatergic and GABAergic imaging in neurological and psychiatric diseases. SFB 779 Colloquium: Otto-von-Guericke-Universität, Magdeburg, Germany (2009)

Henning, A.: MRS and MRI at high and ultra-high field. 7T User Group Colloquium: Vanderbuilt University, Nashville, TN, USA (2009)

Henning, A.: MRS and MRI at high and ultra-high field. Radiology Colloquium: UCLA, Los Angeles, CA, USA (2009)

Henning, A.: Recent advances in quantitative MRS. AAPM 51st Annual Meeting, Anaheim, CA, USA (2009)

Henning, A.: Towards quantitative MRS at 7T. 7T Philips User Meeting, Dallas, TX, USA (2009)